重症登革热合并噬血细胞性淋巴组织细胞增生症:180例重症登革热患者经验
该研究为马来西亚某三级医院ICU的5年回顾性单中心研究,纳入180例成人重症登革热患者。AST、肌酐峰值及SOFA评分为死亡的独立危险因素。
要点
- 重症登革热患者中约12%符合HLH标准,该组死亡率高,应警惕登革热-HLH。
- AST、肌酐峰值升高及SOFA评分升高为重症登革热死亡的独立危险因素。
- 对高炎症反应及多器官衰竭的重症登革热患者,建议前瞻性研究及时启动HLH导向治疗。
核心结论
- 重症登革热患者中登革热-HLH并不少见且死亡率高,应保持警惕。
- 建议对存在高炎症反应及进展性多器官衰竭、有发生登革热-HLH风险的重症登革热患者,开展及时HLH导向治疗的前瞻性研究。
研究设计与样本
- 5年回顾性单中心研究,纳入马来西亚某三级医院ICU收治的全部180例成人重症登革热患者。
主要发现
- 180例重症登革热患者中39例(22%)死亡。
- 符合≥4条HLH-2004诊断标准的31例中12例(39%)死亡,符合≥5条的9例中7例(78%)死亡。
- AST、ALT、LDH、肌酐峰值与死亡相关(OR分别为2.9、3.4、5.8、31.9,均P<.0001),铁蛋白峰值(OR 2.5,P=.0028)、血小板最低值(OR 1.9,P=.00068)、肝大(OR 2.9,P=.012)及年龄增加(OR 1.2,P=.0043)亦与死亡相关。
- 多因素logistic回归显示AST峰值(OR 2.8,P=.0019)、肌酐峰值(OR 7.3,P=.0065)及SOFA评分(OR 1.4,P=.0051)为死亡的独立危险因素。
关键数值与推荐
- HLH定义采用HScore的HLH概率≥70%,亦报告符合≥4条及≥5条HLH-2004诊断标准的死亡情况。
- 原文提及HLH导向治疗包括依托泊苷和地塞米松,但未给出剂量。
临床怎么用
- 对重症登革热患者应监测HLH相关指标,警惕登革热-HLH的高死亡率。
- 关注AST、肌酐峰值及SOFA评分升高者,其死亡风险更高。
局限性
- 回顾性单中心研究,样本来自单一三级医院ICU。
- HLH定义基于HScore概率,研究未报告HLH导向治疗的前瞻性干预数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Globally, ~500 000 people with severe dengue (SD) require hospitalization yearly; ~12 500 (2.5%) die. Secondary hemophagocytic lymphohistiocytosis (sHLH) is a potentially fatal hyperinflammatory condition for which HLH-directed therapy (as etoposide and dexamethasone) can be life-saving. Prompted by the high mortality in SD and the increasing awareness that patients with SD may develop sHLH, our objectives were to (1) determine the frequency of dengue-HLH in SD, (2) describe clinical features of dengue-HLH, (3) assess mortality rate in SD and dengue-HLH, and (4) identify mortality-associated risk factors in SD. METHODS: A 5-year retrospective single-center study in all adult patients with SD admitted to a tertiary intensive care unit in Malaysia. RESULTS: Thirty-nine of 180 (22%) patients with SD died. Twenty-one of 180 (12%) had HLH defined as an HLH probability ≥70% according to histo score (HScore); 9 (43%) died. Similarly, 12 of 31 (39%) fulfilling ≥4 and 7 of 9 (78%) fulfilling ≥5 HLH-2004 diagnostic criteria died. Peak values of aspartate aminotransferase (AST), alanine aminotransferase, lactate dehydrogenase, and creatinine correlated to fatality (odds ratios [ORs], 2.9, 3.4, 5.8, and 31.9; all P < .0001), as did peak ferritin (OR, 2.5; P = .0028), nadir platelets (OR, 1.9; P = .00068), hepatomegaly (OR, 2.9; P = .012), and increasing age (OR, 1.2; P = .0043). Multivariable logistic regression revealed peak AST (OR, 2.8; P = .0019), peak creatinine (OR, 7.3; P = .0065), and SOFA (Sequential Organ Failure Assessment) score (OR, 1.4; P = .0051) as independent risk factors of death. CONCLUSIONS: Be observant of dengue-HLH due to its high mortality. A prospective study is suggested on prompt HLH-directed therapy in SD patients with hyperinflammation and evolving multiorgan failure at risk of developing dengue-HLH.
引用
- Kan FK, Tan CC, Von Bahr Greenwood T, et al. Dengue Infection Complicated by Hemophagocytic Lymphohistiocytosis: Experiences From 180 Patients With Severe Dengue. Clin Infect Dis. 2020. PMID: 31188423. doi:10.1093/cid/ciz499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。